menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

The Impact of Pharmacy Issues in Long-Term Care

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    As medication costs continue rising, what strategies can help long-term care facilities reduce drug expenditures, while still providing the best quality of care for patients? Fred Wendt, RPh, vice president of pharmacy services for Senior PharmaStrategies in Burleson, Texas, says one of the most significant pharmacy issues in long-term care is the Drug Enforcement Administration's current position on the nursing facility staff as agent of the physician, with regard to controlled substances. How is the role of the consultant pharmacist changing in long-term care? What programs can help long-term care facilities reign in drug costs, while maintaining high quality care for patients, particularly in the area of diabetes? Dr. Eric Tangalos hosts.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    As medication costs continue rising, what strategies can help long-term care facilities reduce drug expenditures, while still providing the best quality of care for patients? Fred Wendt, RPh, vice president of pharmacy services for Senior PharmaStrategies in Burleson, Texas, says one of the most significant pharmacy issues in long-term care is the Drug Enforcement Administration's current position on the nursing facility staff as agent of the physician, with regard to controlled substances. How is the role of the consultant pharmacist changing in long-term care? What programs can help long-term care facilities reign in drug costs, while maintaining high quality care for patients, particularly in the area of diabetes? Dr. Eric Tangalos hosts.

Facebook Comments

Schedule19 Mar 2024